Unicycive Therapeutics faces securities class action tied to NDA statements
Unicycive Therapeutics reported a securities class action filed alleging misleading statements about its oxylanthanum carbonate NDA; the company says it will defend the suit.Key Highlights:Original SEC Filing: Unicycive Therapeutics, Inc. [ UNCY ] - 8-K - Sep. 28, 2026This is an AI-powered summary…